$0.649600
0.00961.50%
Last update: 9:29 AM
15 minutes delayed
Comments
Loading...
Evogene
EVGNNASDAQ
Evogene (NASDAQ:EVGN) Stock, Analyst Ratings, Price Targets, Forecasts
Evogene Ltd has a consensus price target of $5.17 based on the ratings of 5 analysts. The high is $8 issued by Aegis Capital on September 12, 2022. The low is $1.85 issued by Alliance Global Partners on October 2, 2023. The 3 most-recent analyst ratings were released by Alliance Global Partners, Lake Street, and Roth MKM on October 2, 2023, August 18, 2023, and July 21, 2023, respectively. With an average price target of $3.62 between Alliance Global Partners, Lake Street, and Roth MKM, there's an implied 456.75% upside for Evogene Ltd from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Alliance Global Partners
Lake Street
Roth MKM
Aegis Capital
Roth Capital
1calculated from analyst ratings
Analyst Ratings for Evogene
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 10/02/2023 | Buy Now | 184.79% | Alliance Global Partners | Ben Haynor | → $1.85 | Initiates | → Buy | Get Alert |
| 08/18/2023 | Buy Now | 361.82% | Lake Street | Ben Klieve | $2 → $3 | Maintains | Buy | Get Alert |
| 07/21/2023 | Buy Now | 823.65% | Roth MKM | Brian Wright | $1 → $6 | Maintains | Buy | Get Alert |
| 05/02/2023 | Buy Now | 207.88% | Lake Street | Ben Klieve | → $2 | Initiates | → Buy | Get Alert |
| 09/12/2022 | Buy Now | 1131.53% | Aegis Capital | Nathan Weinstein | $10 → $8 | Maintains | Buy | Get Alert |
| 09/02/2022 | Buy Now | 361.82% | Roth MKM | Brian Wright | $6 → $3 | Maintains | Buy | Get Alert |
| 10/08/2021 | Buy Now | 977.59% | Roth Capital | — | — | Initiates | → Buy | Get Alert |
| 07/29/2021 | Buy Now | 1439.41% | Aegis Capital | Nathan Weinstein | — | Initiates | → Buy | Get Alert |
FAQ
What is the target price for Evogene (EVGN) stock?
The latest price target for Evogene (NASDAQ:EVGN) was reported by Alliance Global Partners on October 2, 2023. The analyst firm set a price target for $1.85 expecting EVGN to rise to within 12 months (a possible 184.79% upside). 3 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Evogene (EVGN)?
The latest analyst rating for Evogene (NASDAQ:EVGN) was provided by Alliance Global Partners, and Evogene initiated their buy rating.
When was the last upgrade for Evogene (EVGN)?
There is no last upgrade for Evogene
When was the last downgrade for Evogene (EVGN)?
There is no last downgrade for Evogene.
When is the next analyst rating going to be posted or updated for Evogene (EVGN)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Evogene, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Evogene was filed on October 2, 2023 so you should expect the next rating to be made available sometime around October 2, 2024.
Is the Analyst Rating Evogene (EVGN) correct?
While ratings are subjective and will change, the latest Evogene (EVGN) rating was a initiated with a price target of $0.00 to $1.85. The current price Evogene (EVGN) is trading at is $0.65, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.